A leading therapeutic molecule for multiple sclerosis, FTY720, is shown to mimic a key component of sphingolipid signaling, resulting in specific manipulation of histone deacetylases and the extinction of memory.
References
Hait, N.C. et al. Science 325, 1254–1257 (2009).
Hait, N.C. et al. Nat. Neurosci. 17, 971–980 (2014).
Brinkmann, V. et al. Nat. Rev. Drug Discov. 9, 883–897 (2010).
Brinkmann, V. et al. J. Biol. Chem. 277, 21453–21457 (2002).
Zemann, B. et al. Blood 15, 1454–1458 (2006).
McQuown, S.C. et al. J. Neurosci. 31, 764–774 (2011).
Peixoto, L. & Abel, T. Neuropsychopharmacology 38, 62–76 (2013).
Day, J.J. & Sweatt, J.D. Neuron 70, 813–829 (2011).
Lattal, K.M. & Wood, M.A. Nat. Neurosci. 16, 124–129 (2013).
Lattal, K.M., Barrett, R.M. & Wood, M.A. Behav. Neurosci. 121, 1125–1131 (2007).
Bredy, T.W. et al. Learn. Mem. 14, 268–276 (2007).
Malvaez, M. et al. Proc. Natl. Acad. Sci. USA 110, 2647–2652 (2013).
Morris, M.J. et al. J. Neurosci. 33, 6401–6411.
Bahari-Javan, S. et al. J. Neurosci. 32, 5062–5073 (2012).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Matheos, D., Wood, M. Unlocking the constraints on memory formation. Nat Neurosci 17, 895–896 (2014). https://doi.org/10.1038/nn.3748
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3748
- Springer Nature America, Inc.